Happy Nice Mall

President Biden on Monday, a veteran biotechnologist, Dr. Renee Wegrzyn to head an agency created in March to “push the limits” of medical health research and innovation.

Speaking about his cancer initiative from Boston, Mr. Biden, as the inaugural director of the Advanced Research Projects Agency for Health (ARPA-H), Dr. He will detail Wegrzyn’s role. The agency’s portfolio and budget will focus in part on creating programs and technologies that detect, prevent and treat diseases such as cancer.

“Cancer affects all Americans, not just Democrats and Republicans,” the White House said in a briefing before the speech. “When we come together as a nation around ideas that unite us – like fighting cancer – we can show the world that anything is possible.”

Mr. Biden He said Wegrzyn worked at the two institutions that inspired the creation of ARPA-H, the Defense Advanced Research Projects Agency (DARPA) and the Intelligence Advanced Research Projects Activity (IARPA). He is vice president of business development at Ginkgo Bioworks and head of innovation at Concentric by Ginkgo, where he specializes in using synthetic biology to combat disease.

Mr. Biden’s appointment will form a blueprint for his speech on his groundbreaking initiative in cancer, the effort to reduce the US cancer rate by at least 50% over the next 25 years.

Cancer research is personal to Mr. Biden. Her son Beau died of an aggressive form of brain cancer in 2015.

Mr. Biden will deliver his speech on the 60th anniversary of the month’s last speech at Rice University, where President John F. Kennedy pledged to send a man to the moon and bring him back.

“When President Kennedy Moonshot gave his speech, the United States had the building blocks for knowing what was possible. However, there were major scientific and societal advances that needed to happen. “As a nation, we needed to be fully committed to a future where it was possible to travel to the moon, and that’s exactly what we did,” the White House said. “Today we have many of the building blocks needed to make significant progress in the fight against cancer, but we must come together to deliver on that promise fairly.”

Mr. Biden will also sign an executive order Monday to boost local biotechnology and reduce the US reliance on foreign biomanufacturing.

Officials said the order will help secure US leadership in the development and production of key technologies used in products ranging from jet fuels to pharmaceuticals.

“The United States really has the best biotech innovators in the world,” said a senior management official. But if we don’t translate biotech innovation into economic benefits for all Americans, we risk falling behind, as has happened in the semiconductor industry and advanced telecommunications industry.”

“Other countries, especially China, are investing aggressively in the sector, which poses a risk to the US leadership unless they take action as we are with this executive order,” the official said.

Also Monday, Mr. Biden will say the signature tax and climate bill includes provisions that will reduce prescription costs for cancer patients; To summarize the National Cancer Institute’s efforts to detect cancer and develop the next generation of cancer researchers; and highlight a Department of Defense program to understand cancers in military members exposed to toxic substances.